- Home
- SOPH vs JGH Comparison
SOPH vs JGH Comparison
Compare SOPH & JGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPH
- JGH
- Stock Information
- Founded
- SOPH 2011
- JGH 2014
- Country
- SOPH Switzerland
- JGH United States
- Employees
- SOPH N/A
- JGH N/A
- Industry
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- JGH Investment Managers
- Sector
- SOPH Health Care
- JGH Finance
- Exchange
- SOPH Nasdaq
- JGH Nasdaq
- Market Cap
- SOPH 247.0M
- JGH 304.1M
- IPO Year
- SOPH 2021
- JGH N/A
- Fundamental
- Price
- SOPH $3.40
- JGH $12.97
- Analyst Decision
- SOPH Strong Buy
- JGH
- Analyst Count
- SOPH 3
- JGH 0
- Target Price
- SOPH $7.00
- JGH N/A
- AVG Volume (30 Days)
- SOPH 21.9K
- JGH 73.9K
- Earning Date
- SOPH 11-05-2024
- JGH 01-01-0001
- Dividend Yield
- SOPH N/A
- JGH 9.85%
- EPS Growth
- SOPH N/A
- JGH N/A
- EPS
- SOPH N/A
- JGH N/A
- Revenue
- SOPH $64,938,000.00
- JGH N/A
- Revenue This Year
- SOPH $7.70
- JGH N/A
- Revenue Next Year
- SOPH $20.61
- JGH N/A
- P/E Ratio
- SOPH N/A
- JGH N/A
- Revenue Growth
- SOPH 20.14
- JGH N/A
- 52 Week Low
- SOPH $2.70
- JGH $10.36
- 52 Week High
- SOPH $7.37
- JGH $12.85
- Technical
- Relative Strength Index (RSI)
- SOPH 44.10
- JGH 38.66
- Support Level
- SOPH $3.22
- JGH $12.99
- Resistance Level
- SOPH $3.66
- JGH $13.15
- Average True Range (ATR)
- SOPH 0.20
- JGH 0.11
- MACD
- SOPH 0.01
- JGH -0.05
- Stochastic Oscillator
- SOPH 58.60
- JGH 13.73
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About JGH Nuveen Global High Income Fund of Beneficial Interest
Nuveen Global High Income Fund operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of current income. Its securities include U.S. high-yield bonds; non-U.S. high-yield bonds from developed and emerging markets; and other income-producing investments such as preferred and convertible securities.